Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $131.00.

Several equities research analysts recently issued reports on ADUS shares. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th. Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Royal Bank Of Canada reiterated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th. Barclays dropped their price target on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Finally, Stephens cut their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th.

View Our Latest Report on Addus HomeCare

Addus HomeCare Price Performance

ADUS stock opened at $92.70 on Wednesday. The company has a market capitalization of $1.73 billion, a P/E ratio of 17.13, a price-to-earnings-growth ratio of 1.24 and a beta of 0.89. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. Addus HomeCare has a 52-week low of $87.95 and a 52-week high of $124.43. The business has a 50-day simple moving average of $93.78 and a two-hundred day simple moving average of $103.64.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings data on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. During the same period in the prior year, the business posted $1.42 earnings per share. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. Research analysts expect that Addus HomeCare will post 6.24 EPS for the current fiscal year.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently modified their holdings of ADUS. Capital Research Global Investors grew its holdings in shares of Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after acquiring an additional 268,192 shares in the last quarter. Freestone Grove Partners LP boosted its position in Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after purchasing an additional 135,246 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Addus HomeCare by 11.8% in the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after purchasing an additional 78,415 shares during the last quarter. 8 Knots Management LLC bought a new position in Addus HomeCare in the 3rd quarter valued at $6,075,000. Finally, Empowered Funds LLC increased its position in shares of Addus HomeCare by 186.1% during the 4th quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after purchasing an additional 46,137 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.